ARTICLE | Clinical News
Ixmyelocel-T: Phase IIb ongoing
April 14, 2014 7:00 AM UTC
Aastrom said an independent DSMB recommended continuation of the double-blind, placebo-controlled, U.S. Phase IIb ixCELL-DCM trial of ixmyelocel-T based on a planned interim review of unblinded safety...